Role of Positive Affect in Adjustment to HIV - Full Text View

Role of Positive Affect in Adjustment to HIV (CHAI)

This study is ongoing, but not recruiting participants.

First Received: December 19, 2007 Last Updated: October 15, 2008 History of Changes

Sponsors and Collaborators:	University of California, San Francisco National Institute of Mental Health (NIMH)
Information provided by:	University of California, San Francisco
ClinicalTrials.gov Identifier:	NCT00582023

Purpose

The purpose of this study is to examine the role of emotion and mood in the context of HIV.

Condition
HIV Infections

MedlinePlus related topics: AIDS

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort
Official Title:	CHAI Study: Coping, HIV, and Affect Interview Study

Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:

Well being [ Time Frame: 18 month follow-up ] [ Designated as safety issue: No ]
Physical & Mental Health [ Time Frame: 18 months ] [ Designated as safety issue: No ]
Coping Response [ Time Frame: 18 months ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	300
Study Start Date:	September 2004
Estimated Study Completion Date:	June 2009

Detailed Description:

A growing body of literature indicates that positive affect may have a unique adaptive role in the process of adjustment to chronic stress, independent of the effects of negative affects like depression. The overarching goal of this research is to provide evidence and direction for the development of interventions for people with HIV that include a focus on positive affect. To this end, this study will document the occurrence, predictors, and consequences of positive affect during the 18 months post-notification of HIV+ serostatus.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Adults newly diagnosed with HIV in the San Franicsco Bay Area.

Criteria

Inclusion Criteria:

Have been informed they were HIV positive within the past two months
Speak English
Be 18 years or older
Have the ability to provide informed consent to be a research participant

Exclusion Criteria:

Severe cognitive impairment
Active psychosis

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00582023

Locations

United States, California
Osher Center for Integrative Medicine, UCSF
San Francisco, California, United States, 94115

Sponsors and Collaborators

University of California, San Francisco

National Institute of Mental Health (NIMH)

Investigators

Principal Investigator:

Judith Moskowitz, PhD, MPH

University of California, San Francisco

More Information

No publications provided

Responsible Party:	Osher Center for Integrative Medicine, UCSF ( Judith Moskowitz, Phd, MPH )
Study ID Numbers:	CHAI 971423990, R01 MH068170
Study First Received:	December 19, 2007
Last Updated:	October 15, 2008
ClinicalTrials.gov Identifier:	NCT00582023 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by University of California, San Francisco:

HIV
coping
emotion

affect
HIV infection
Complimentary therapies

Study placed in the following topic categories:

Virus Diseases
Sexually Transmitted Diseases, Viral
HIV Infections
Sexually Transmitted Diseases

Acquired Immunodeficiency Syndrome
Retroviridae Infections
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:

Virus Diseases
Sexually Transmitted Diseases, Viral
RNA Virus Infections
Slow Virus Diseases
Immune System Diseases
HIV Infections

Sexually Transmitted Diseases
Acquired Immunodeficiency Syndrome
Lentivirus Infections
Infection
Retroviridae Infections
Immunologic Deficiency Syndromes

ClinicalTrials.gov processed this record on May 07, 2009